Internal Oncology Programs

About PhoreMost

PhoreMost is a private biotechnology company pioneering a novel approach to early-stage drug discovery by combining sophisticated phenotypic screening with AI to illuminate new therapeutic pathways, particularly in oncology. Its proprietary platform, SITESEEKER®, is designed to identify and validate previously inaccessible drug targets, enabling the development of first-in-class medicines. The company advances its own pipeline while also engaging in strategic partnerships to expand the reach and impact of its technology. As a pre-revenue, pre-clinical stage entity, its success hinges on translating platform hits into viable clinical candidates and securing continued partnership and investment funding.

Therapeutic Areas

Other Oncology (unspecified) Drugs